comparemela.com

Latest Breaking News On - Stifel nicolaus europe limited joint corporate broker - Page 16 : comparemela.com

Investegate |Uniphar PLC Announcements | Uniphar PLC: Currency Change on LSE

  Headquartered in Dublin, Ireland, Uniphar plc ( Uniphar and together with its subsidiaries the Group ) is an international diversified healthcare services business, servicing the requirements of more than 200 multinational pharmaceutical and medical technology manufacturers across three divisions - Commercial & Clinical, Product Access and Supply Chain & Retail.   The Group has strong established relationships with 7 of the top 10 pharma companies and 6 of the top 10 medical device companies. With a workforce of more than 2,500, the Group is active in Ireland, the UK, the Benelux, the Nordics and the US, delivering unlicensed and specialty medicine on a global basis.   The Group s vision is to improve patient access to pharmaco-medical products and treatments by enhancing connectivity between manufacturers and healthcare stakeholders. Uniphar represents a strong combination of scale, growth and profitability.

Uniphar PLC (Ireland:UPR) | RNS | Uniphar PLC - Currency Change on LSE

Uniphar PLC (Ireland:UPR) | RNS | Uniphar PLC - Currency Change on LSE
proactiveinvestors.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from proactiveinvestors.co.uk Daily Mail and Mail on Sunday newspapers.

Investegate |Yourgene Health PLC Announcements | Yourgene Health PLC: DPYD screening recommended in Belgium

About Yourgene Health Yourgene Health is an international molecular diagnostics group which develops and commercialises genetic products and services. The group works in partnership with global leaders in DNA technology to advance diagnostic science.   Yourgene primarily develops, manufactures, and commercialises simple and accurate molecular diagnostic solutions, for reproductive health, precision medicine and now infectious diseases. The Group s flagship products include non-invasive prenatal tests (NIPT) for Down s Syndrome and other genetic disorders, Cystic Fibrosis screening tests, invasive rapid aneuploidy tests, and a recent extension into the oncology space with DPYD genotyping.   The launch of Yourgene Genomic Services has enabled Yourgene to offer a global laboratory service network equipped to be a full life-cycle partner for clinical, research and pharmaceutical organisations to support partners at the preclinical, clinical, and post-market stages to develop, manu

Investegate |Yourgene Health PLC Announcements | Yourgene Health PLC: Issue of Share Options

Investegate |Yourgene Health PLC Announcements | Yourgene Health PLC: COVID-19 update

About Yourgene Health Yourgene Health is an international molecular diagnostics group which develops and commercialises genetic products and services. The group works in partnership with global leaders in DNA technology to advance diagnostic science.   Yourgene primarily develops, manufactures, and commercialises simple and accurate molecular diagnostic solutions, for reproductive health, precision medicine and now infectious diseases. The Group s flagship products include non-invasive prenatal tests (NIPT) for Down s Syndrome and other genetic disorders, Cystic Fibrosis screening tests, invasive rapid aneuploidy tests, and a recent extension into the oncology space with DPYD genotyping.   The launch of Yourgene Genomic Services has enabled Yourgene to offer a global laboratory service network equipped to be a full life-cycle partner for clinical, research and pharmaceutical organisations to support partners at the preclinical, clinical, and post-market stages to develop, manu

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.